Silexion Therapeutics Ltd.SLXNNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank26
Year-over-Year Change
Year-over-year free cash flow growth rate
Percentile
P26
Within normal range
vs 3Y Ago
0x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -13.36% |
| Q2 2025 | -1.99% |
| Q1 2025 | 15.96% |
| Q4 2024 | -9.63% |
| Q3 2024 | -150.61% |
| Q2 2024 | 39.42% |
| Q1 2024 | 65.08% |
| Q4 2023 | -628.56% |
| Q3 2023 | -4846.31% |
| Q2 2023 | -102.63% |
| Q1 2023 | -19.46% |
| Q4 2022 | 86.24% |
| Q3 2022 | 712.77% |
| Q2 2022 | 58.84% |
| Q1 2022 | 62.36% |
| Q4 2021 | 0.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |